Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

MasterBrand (MBC) Asset Writedowns and Impairment (2022 - 2023)

MasterBrand (MBC) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $4.6 million as the latest value for Q4 2023.

Quarterly Asset Writedowns and Impairment fell 77.45% to $4.6 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $25.0 million through Dec 2023, changed N/A year-over-year, with the annual reading at $17.8 million for FY2025, 4350.0% up from the prior year.
Asset Writedowns and Impairment for Q4 2023 was $4.6 million at MasterBrand, down from $20.4 million in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $26.0 million in Q2 2022, with the low at $4.6 million in Q4 2023.